Puisset, F.; Mseddi, M.; Mourey, L.; Pouessel, D.; Blanchet, B.; Chatelut, E.; Chevreau, C.
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer. Cancers 2023, 15, 313.
https://doi.org/10.3390/cancers15010313
AMA Style
Puisset F, Mseddi M, Mourey L, Pouessel D, Blanchet B, Chatelut E, Chevreau C.
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer. Cancers. 2023; 15(1):313.
https://doi.org/10.3390/cancers15010313
Chicago/Turabian Style
Puisset, Florent, Mourad Mseddi, Loïc Mourey, Damien Pouessel, Benoit Blanchet, Etienne Chatelut, and Christine Chevreau.
2023. "Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer" Cancers 15, no. 1: 313.
https://doi.org/10.3390/cancers15010313
APA Style
Puisset, F., Mseddi, M., Mourey, L., Pouessel, D., Blanchet, B., Chatelut, E., & Chevreau, C.
(2023). Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer. Cancers, 15(1), 313.
https://doi.org/10.3390/cancers15010313